Please login to the form below

Not currently logged in
Email:
Password:

MM-398

This page shows the latest MM-398 news and features for those working in and with pharma, biotech and healthcare.

Baxter and Merrimack file pancreatic cancer drug in EU

Baxter and Merrimack file pancreatic cancer drug in EU

Baxter and Merrimack file pancreatic cancer drug in EU. MM-398 is thought to help direct the active drug into tumours. ... Analysts have suggested MM-398 could become a $500m-a-year product at peak.

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Complete Medical

Complete Medical delivers world-class solutions in medical communications, regulatory services, healthcare multichannel excellence, and strategic consultancy. We bring together specialist...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics